Intellia heads to FDA with first in vivo CRISPR-based gene editing therapy

Nature Biotechnology, Published online: 18 May 2026; doi:10.1038/s41587-026-03154-9

Intellia heads to FDA with first in vivo CRISPR-based gene editing therapy